Chronic Myeloproliferative Disorders Treatment - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Chronic Myeloproliferative Disorders Treatment (PDQ®)

Patient Version Health Professional Version En español

Last Modified: 05/08/2008


Purpose of This PDQ Summary


General Information


Chronic Myelogenous Leukemia


Polycythemia Vera


Chronic Idiopathic Myelofibrosis


Essential Thrombocythemia


Chronic Neutrophilic Leukemia


Chronic Eosinophilic Leukemia


Get More Information From NCI


Changes to This Summary (05/08/2008)


More Information

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate New Study of Targeted Therapies for Breast Cancer The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

You CAN Quit Smoking Now!

Chronic Myelogenous Leukemia

Refer to the PDQ summary on Chronic Myelogenous Leukemia Treatment for more information.

< Previous Section | Next Section >

| | | | | | | |

A Service of the National Cancer Institute